| 6401 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
60 |
| 6402 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
19 |
| 6403 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6404 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
22 |
| 6405 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6406 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
46 |
| 6407 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
23 |
| 6408 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
69 |
| 6409 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6410 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
17 |
| 6411 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
31 |
| 6412 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
66 |
| 6413 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
17 |
| 6414 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
58 |
| 6415 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
11 |
| 6416 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
64 |
| 6417 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
30 |
| 6418 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
54 |
| 6419 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
72 |
| 6420 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6421 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6422 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
63 |
| 6423 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
48 |
| 6424 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6425 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6426 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
51 |
| 6427 |
Apheresis |
Allogeneic |
Other Malignancy |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6428 |
Apheresis |
Allogeneic |
Other Myelodysplastic Syndromes |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6429 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Poland |
57 |
| 6430 |
Apheresis |
Allogeneic |
Peripheral T-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6431 |
Apheresis |
Allogeneic |
Plasma Cell Disorder |
Hematology |
2018 |
Standard Therapy |
Poland |
64 |
| 6432 |
Apheresis |
Allogeneic |
Plasma Cell Disorder |
Hematology |
2018 |
Standard Therapy |
Poland |
57 |
| 6433 |
Apheresis |
Autologous |
Plasma Cell Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6434 |
Apheresis |
Allogeneic |
Post-Essential Thrombocythemia-Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Germany |
53 |
| 6435 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6436 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6437 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6438 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
63 |
| 6439 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6440 |
Apheresis |
Allogeneic |
Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
53 |
| 6441 |
Apheresis |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6442 |
Apheresis |
Autologous |
Refractory Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
36 |
| 6443 |
Apheresis |
Allogeneic |
Refractory Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
50 |
| 6444 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
58 |
| 6445 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
68 |
| 6446 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia At Primary Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Germany |
56 |
| 6447 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
18 |
| 6448 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
74 |
| 6449 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
24 |
| 6450 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6451 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
6 |
| 6452 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
13 |
| 6453 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6454 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
7 |
| 6455 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
13 |
| 6456 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6457 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
40 |
| 6458 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6459 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6460 |
Apheresis |
Allogeneic |
T-Cell-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
23 |
| 6461 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
5 |
| 6462 |
Apheresis |
Allogeneic |
Therapy-Related Myelodysplastic Syndromes |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6463 |
Adipose Tissue |
Autologous |
Condition After Injury Of The Left Knee Joint |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
33 |
| 6464 |
Adipose Tissue |
Autologous |
Coxarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
53 |
| 6465 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6466 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6467 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6468 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6469 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6470 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6471 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6472 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6473 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
69 |
| 6474 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
42 |
| 6475 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6476 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6477 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6478 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6479 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6480 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6481 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6482 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6483 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6484 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6485 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6486 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
44,2 |
| 6487 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
25,8 |
| 6488 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
38,5 |
| 6489 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
26,1 |
| 6490 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
37,11 |
| 6491 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
62,5 |
| 6492 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
35,4 |
| 6493 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
31,3 |
| 6494 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
13 |
| 6495 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
11,1 |
| 6496 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
2,4 |
| 6497 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
8,1 |
| 6498 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
7,6 |
| 6499 |
Cord Tissue |
Allogeneic – Unrelated |
Age-Related Macular Degeneration |
Ophthalmology |
2017 |
Experimental Therapy |
Poland |
33,4 |
| 6500 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
67,11 |